CureVac has sued BioNTech over its mRNA technology. The German-based biotech company charges that BioNTech has infringed upon its intellectual property rights. (Reuters)

Anebulo Pharmaceuticals has created a potential antidote for cannabis intoxication. A single dose of the experimental pill halted the psychoactive effects participants experienced when under the influence of marijuana. (STAT)

A federal judge ruled that the nation’s three largest drug distributors are not liable for the opioid epidemic in two West Virginia counties. The judge ruled in favor of AmerisourceBergen, McKesson and Cardinal Health. (The New York Times)

The BA.4 and BA.5 Omicron subvariants are responsible for 70% of new COVID cases, the Centers for Disease Control and Prevention said. That percentage is up from 55% of new cases the week prior. (U.S. News & World Report)

Amylyx Pharmaceuticals’ ALS drug will receive another look from Food and Drug Administration advisors. The company had planned on discontinuing operations if the FDA didn’t agree to reexamine the trial data. (Endpoints News)